BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Toshikuni N, Tsutsumi M, Arisawa T. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8393-8406 [PMID: 25024597 DOI: 10.3748/wjg.v20.i26.8393]
URL: https://www.wjgnet.com/1948-5182/full/v20/i26/8393.htm
Number Citing Articles
1
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation RelevanceMedicina 2023; 59(9): 1614 doi: 10.3390/medicina59091614
2
Hiral Aghara, Prashsti Chadha, Devangi Zala, Palash Mandal. Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticlesFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1205821
3
Ashal Ilyas, Yasanandana Supunsiri Wijayasinghe, Ilyas Khan, Nourhan M. El Samaloty, Mohd Adnan, Tanveer Ali Dar, Nitesh Kumar Poddar, Laishram R. Singh, Hemlata Sharma, Shahanavaj Khan. Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective CompoundsFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.964624
4
Bo Yoon Chang, Hyung Joong Kim, Tae Young Kim, Sung Yeon Kim. Enzyme-Treated Zizania latifolia Extract Protects against Alcohol-Induced Liver Injury by Regulating the NRF2 PathwayAntioxidants 2021; 10(6): 960 doi: 10.3390/antiox10060960
5
Lauren Weaver, Abdul-rizaq Hamoud, David E. Stec, Terry D. Hinds. Biliverdin reductase and bilirubin in hepatic diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 314(6): G668 doi: 10.1152/ajpgi.00026.2018
6
Marica Meroni, Miriam Longo, Raffaela Rametta, Paola Dongiovanni. Genetic and Epigenetic Modifiers of Alcoholic Liver DiseaseInternational Journal of Molecular Sciences 2018; 19(12): 3857 doi: 10.3390/ijms19123857
7
Ali Zarrinpar, Claire M. Faltermeier, Vatche G. Agopian, Bita V. Naini, Michael P. Harlander‐Locke, Fady M. Kaldas, Douglas G. Farmer, Ronald W. Busuttil. Metabolic factors affecting hepatocellular carcinoma in steatohepatitisLiver International 2019; 39(3): 531 doi: 10.1111/liv.14002
8
Sumi Sung, Jieun Kim, Youngmi Jung. Liver-Derived Exosomes and Their Implications in Liver PathobiologyInternational Journal of Molecular Sciences 2018; 19(12): 3715 doi: 10.3390/ijms19123715
9
Savneet Kaur, Rashi Sehgal, Saggere M. Shastry, Geoffrey McCaughan, Helen M. McGuire, Barbara Fazekas St de Groth, Shiv Sarin, Nirupma Trehanpati, Devanshi Seth. Circulating Endothelial Progenitor Cells Present an Inflammatory Phenotype and Function in Patients With Alcoholic Liver CirrhosisFrontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00556
10
Yoosoo Chang, Yong Kyun Cho, Juhee Cho, Hyun-Suk Jung, Kyung Eun Yun, Jiin Ahn, Chong Il Sohn, Hocheol Shin, Seungho Ryu. Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort StudyAmerican Journal of Gastroenterology 2019; 114(4): 620 doi: 10.14309/ajg.0000000000000074
11
Bo Li, Shan-Shan Lei, Jie Su, Xia-Miao Cai, Hao Xu, Xinglishang He, Ye-Hui Chen, Hai-Xia Lu, He Li, Liu-Qing Qian, Xiang Zheng, Gui-Yuan Lv, Su-Hong Chen. Alcohol Induces More Severe Fatty Liver Disease by Influencing Cholesterol MetabolismEvidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/7095684
12
Stephen Malnick, Yaakov Maor. The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic SyndromeVisceral Medicine 2020; 36(3): 198 doi: 10.1159/000507233
13
Vetriselvan Subramaniyan, Natasha Sura Anak Lubau, Nobendu Mukerjee, Vinoth Kumarasamy. Alcohol-induced liver injury in signalling pathways and curcumin's therapeutic potentialToxicology Reports 2023; 11: 355 doi: 10.1016/j.toxrep.2023.10.005
14
Jihye Lim, Hyunji Sang, Ha Il Kim. Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver diseaseJHEP Reports 2023; 5(6): 100721 doi: 10.1016/j.jhepr.2023.100721
15
Meilan Xue, Yingjie Tian, Yingzhong Sui, Hui Zhao, Haiqi Gao, Hui Liang, Xia Qiu, Zhanyi Sun, Yi Zhang, Yimin Qin. Protective effect of fucoidan against iron overload and ferroptosis-induced liver injury in rats exposed to alcoholBiomedicine & Pharmacotherapy 2022; 153: 113402 doi: 10.1016/j.biopha.2022.113402
16
Fei Xie, Yifei Song, Yang Yi, Xue Jiang, Shiwen Ma, Chen Ma, Junyu Li, Ziyi Zhanghuang, Mengyu Liu, Pengxiang Zhao, Xuemei Ma. Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to BedsidePharmaceuticals 2023; 16(4): 541 doi: 10.3390/ph16040541
17
J. Jadzic, P. Milovanovic, N. Tomanovic, V. Zivkovic, D. Djukic, S. Nikolic, M. Djuric, D. Djonic. Micro-scale vertebral features in postmenopausal women with alcohol-associated and metabolic-associated fatty liver disease: ex vivo bone quality analysesJournal of Endocrinological Investigation 2023; 47(1): 131 doi: 10.1007/s40618-023-02130-3
18
Hyunna Jung, Sohyeon You, Soo-Im Choi, Chang-Ho Kang, Gun-Hee Kim. Levilactobacillus brevis MG5311 Alleviates Ethanol-Induced Liver Injury by Suppressing Hepatic Oxidative Stress in C57BL/6 MiceMicroorganisms 2022; 10(12): 2488 doi: 10.3390/microorganisms10122488
19
Zehra N. Kocas-Kilicarslan, Zeliha Cetin, Lanuza A.P. Faccioli, Takashi Motomura, Sriram Amirneni, Ricardo Diaz-Aragon, Rodrigo M. Florentino, Yiyue Sun, Iris Pla-Palacin, Mengying Xia, Mark T. Miedel, Takeshi Kurihara, Zhiping Hu, Alina Ostrowska, Zi Wang, Robert Constantine, Albert Li, D. Lansing Taylor, Jaideep Behari, Alejandro Soto-Gutierrez, Edgar N. Tafaleng. Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver DiseaseGastro Hep Advances 2024; 3(1): 67 doi: 10.1016/j.gastha.2023.09.011
20
Sowbhikh Krishnan M, Sudha R. A STUDY OF NONALCOHOLIC FATTY LIVER DISEASE AND FATTY LIVER INDEX IN TYPE 2 DIABETES MELLITUS PATIENTSJournal of Evidence Based Medicine and Healthcare 2016; 3(57): 3001 doi: 10.18410/jebmh/2016/654
21
Hassan Mumtaz, Madiha Hameed, Abdul Basit Sangah, Amraha Zubair, Mohammad Hasan. Association between smoking and non-alcoholic fatty liver disease in Southeast AsiaFrontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.1008878
22
Sumit Sharma, Akshay Moudgil, Sanjay Singh, Samaresh Das, Prashant Mishra. Highly Sensitive Tungsten Oxide Thin Film‐Based Field‐Effect Transistor for Real‐Time Monitoring of Dissolved Ammonia in Human PlasmaAdvanced Materials Interfaces 2022; 9(19) doi: 10.1002/admi.202200647
23
Abdel Aziz Shaheen, Gilaad G. Kaplan, Keith A. Sharkey, Brendan Cord Lethebe, Mark G. Swain. Impact of major depression and antidepressant use on alcoholic and non‐alcoholic fatty liver disease: A population‐based studyLiver International 2021; 41(10): 2308 doi: 10.1111/liv.14973
24
L. V. Tarasova, V. N. Diomidova, N. V. Tolmacheva, Yu. V. Tsyganova, A. L. Ivanova, J. V. Maslova, E. V. Barsukova. Correlation of secreted frizzled related protein-4 adipokin expression and expression of fatty liver changes under the conditions of a chronic experimentExperimental and Clinical Gastroenterology 2021; 1(5): 44 doi: 10.31146/1682-8658-ecg-189-5-44-48
25
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventionsLife Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
26
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu, Katia C. Karalis. Modeling alcohol-associated liver disease in a human Liver-ChipCell Reports 2021; 36(3): 109393 doi: 10.1016/j.celrep.2021.109393
27
Yoosoo Chang, Seungho Ryu, Ki-Chul Sung, Yong Kyun Cho, Eunju Sung, Han-Na Kim, Hyun-Suk Jung, Kyung Eun Yun, Jiin Ahn, Hocheol Shin, Sarah Helen Wild, Christopher D Byrne. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health StudyGut 2019; 68(9): 1667 doi: 10.1136/gutjnl-2018-317666
28
Poliana C. Marinello, Paola S. Cella, Mayra T.J. Testa, Phillipe B. Guirro, Walison Augusto da Silva Brito, Camila S. Padilha, Alessandra L. Cecchini, Robin P. da Silva, José Alberto R. Duarte, Rafael Deminice. Creatine supplementation protects against diet-induced non-alcoholic fatty liver but exacerbates alcoholic fatty liverLife Sciences 2022; 310: 121064 doi: 10.1016/j.lfs.2022.121064
29
Rongxuan Li, Weiyue Xue, Huiting Wei, Qingqing Fan, Xiang Li, Ye Qiu, Di Cui. Research Progress of Pyroptosis in Fatty Liver DiseaseInternational Journal of Molecular Sciences 2023; 24(17): 13065 doi: 10.3390/ijms241713065
30
Nobuyuki Toshikuni, Mutsumi Tsuchishima, Atsushi Fukumura, Tomiyasu Arisawa, Mikihiro Tsutsumi. Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic SteatohepatitisGastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/9127847
31
Rolf Teschke. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy optionsExpert Opinion on Pharmacotherapy 2018; 19(8): 779 doi: 10.1080/14656566.2018.1465929
32
Piero Portincasa. NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient careInternal and Emergency Medicine 2023; 18(4): 993 doi: 10.1007/s11739-023-03203-0
33
Alejandro Torres‐Hernandez, Wei Wang, Yuri Nikiforov, Karla Tejada, Luisana Torres, Aleksandr Kalabin, Salma Adam, Jingjing Wu, Lu Lu, Ruonan Chen, Aaron Lemmer, Jimmy Camargo, Mautin Hundeyin, Brian Diskin, Berk Aykut, Emma Kurz, Juan A. Kochen Rossi, Mohammed Khan, Miguel Liria, Gustavo Sanchez, Nan Wu, Wenyu Su, Steven Adams, Muhammad Israr Ul Haq, Mohammad Saad Farooq, Varshini Vasudevaraja, Joshua Leinwand, George Miller. γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune ProgrammingHepatology 2020; 71(2): 477 doi: 10.1002/hep.30952
34
Massoud Houshmand, Vahide Zeinali, Amirhossein Hosseini, Atena Seifi, Bardia Danaei, Sharareh Kamfar. Investigation of FGF21 mRNA levels and relative mitochondrial DNA copy number levels and their relation in nonalcoholic fatty liver disease: a case-control studyFrontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1203019
35
Laura Valenzuela-Vallejo, Christos S. Mantzoros. Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD)Metabolism 2022; 134: 155246 doi: 10.1016/j.metabol.2022.155246
36
Jin-Zhou Zhu, Yi-Ning Dai, Yu-Ming Wang, Qin-Yi Zhou, Chao-Hui Yu, You-Ming Li. Prevalence of Nonalcoholic Fatty Liver Disease and EconomyDigestive Diseases and Sciences 2015; 60(11): 3194 doi: 10.1007/s10620-015-3728-3
37
Victory Okpujie, Opeyemi Tobalesi, Fidelis Uwumiro, Amaka C Ugoh, Elsie O Osiogo, Olawale Abesin, Oluwatobi A Olaomi, Chimaobi O Nwevo, Tosin Ayantoyinbo, Franklin Ejeagha. The Influence of Insulin Resistance on Outcomes in Hospitalizations for Alcohol-Related Liver Disease: A Nationwide StudyCureus 2023;  doi: 10.7759/cureus.42964
38
Kamila Misiakiewicz-Has, Dominika Maciejewska-Markiewicz, Sylwia Rzeszotek, Anna Pilutin, Agnieszka Kolasa, Paweł Szumilas, Ewa Stachowska, Barbara Wiszniewska. The Obscure Effect of Tribulus terrestris Saponins Plus Inulin on Liver Morphology, Liver Fatty Acids, Plasma Glucose, and Lipid Profile in SD Rats with and without Induced Type 2 Diabetes MellitusInternational Journal of Molecular Sciences 2021; 22(16): 8680 doi: 10.3390/ijms22168680
39
Sumra Nazir, Vera Jankowski, Guzide Bender, Stephen Zewinger, Kerry-Anne Rye, Emiel P.C. van der Vorst. Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!Advanced Drug Delivery Reviews 2020; 159: 94 doi: 10.1016/j.addr.2020.10.006
40
Perizat Kanabekova, Adina Kadyrova, Gulsim Kulsharova. Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In VitroMicromachines 2022; 13(3): 428 doi: 10.3390/mi13030428
41
Swadha Anand, Sharmila S. Mande. Host-microbiome interactions: Gut-Liver axis and its connection with other organsnpj Biofilms and Microbiomes 2022; 8(1) doi: 10.1038/s41522-022-00352-6
42
Seung Yeon Lee, Donghyun Kim, Seung Hwan Lee, Jong Hwan Sung. Microtechnology-based in vitro models: Mimicking liver function and pathophysiologyAPL Bioengineering 2021; 5(4) doi: 10.1063/5.0061896
43
Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, Aki S. Havulinna, Guillaume Méric, Yang Liu, Rohit Loomba, Yoshiki Vázquez-Baeza, Anupriya Tripathi, Liisa M. Valsta, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J. Niiranen. Links between gut microbiome composition and fatty liver disease in a large population sampleGut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1888673
44
Xi Chen, Xin-Rui Tan, Shi-Jun Li, Xing-Xing Zhang. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver diseaseLife Sciences 2019; 235: 116829 doi: 10.1016/j.lfs.2019.116829
45
Katharina Staufer, Michel Yegles. Biomarkers for detection of alcohol consumption in liver transplantationWorld Journal of Gastroenterology 2016; 22(14): 3725-3734 doi: 10.3748/wjg.v22.i14.3725
46
Taewoo Kim, Dong Hyun Lee, Eun-Kee Park, Sanghun Choi. Deep Learning Techniques for Fatty Liver Using Multi-View Ultrasound Images Scanned by Different Scanners: Development and Validation StudyJMIR Medical Informatics 2021; 9(11): e30066 doi: 10.2196/30066
47
Xiya Li, Zhen Li, Mengmeng Zhang, Guangsen Li, Tingting Yu. Shear wave elastography to evaluate carotid artery elasticity in long‐term drinkers with varying degrees of alcoholic fatty liver diseaseJournal of Clinical Ultrasound 2023; 51(4): 696 doi: 10.1002/jcu.23398
48
Santosh Kumar Behera, Ardhendu Bhusan Praharaj, Gayathri Chalikonda, Gowru Srivani, Namita Mahapatra. Theranostics Approaches to Gastric and Colon CancerDiagnostics and Therapeutic Advances in GI Malignancies 2020; : 167 doi: 10.1007/978-981-15-2017-4_11
49
Si-Si Jin, Chun-Jing Lin, Xian-Fan Lin, Ju-Zeng Zheng, Hua-Qin Guan. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathwayAnnals of Hepatology 2022; 27(2): 100584 doi: 10.1016/j.aohep.2021.100584
50
Claudia Filozof, Barry J. Goldstein, Richard N. Williams, Arun Sanyal. Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayDrugs 2015; 75(12): 1373 doi: 10.1007/s40265-015-0437-3
51
Jillian Price, Carey Escheik, Ali Weinstein, Patrice Winter, Lynn Gerber, Zobair Younossi. Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver diseaseThe Journal of Clinical Hypertension 2020; 22(10): 1915 doi: 10.1111/jch.13938
52
Madushika M. Wimalarathne, Quiana C. Wilkerson-Vidal, Emily C. Hunt, Sharifa T. Love-Rutledge. The case for FAT10 as a novel target in fatty liver diseasesFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.972320
53
Tyler J. Reed, Danielle D'Ambrosio, Barbara E.C. Knollmann-Ritschel. Educational Case: Evaluating a patient with cirrhosisAcademic Pathology 2022; 9(1): 100031 doi: 10.1016/j.acpath.2022.100031
54
Karthik Shree Harini, Devaraj Ezhilarasan. Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseasesHepatobiliary & Pancreatic Diseases International 2023; 22(4): 333 doi: 10.1016/j.hbpd.2022.10.003
55
Jer-Hwa Hsu, I-Chia Chien, Ching-Heng Lin. Increased risk of chronic liver disease in patients with major depressive disorder: A population-based studyJournal of Affective Disorders 2019; 251: 180 doi: 10.1016/j.jad.2019.03.070
56
N. V. Mikhaylova, I. L. Petrunko. Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and DifferencesActa Biomedica Scientifica (East Siberian Biomedical Journal) 2019; 4(3): 23 doi: 10.29413/ABS.2019-4.3.3
57
Chien-Chao Chiu, Yung-Hao Ching, Yen-Peng Li, Ju-Yun Liu, Yen-Te Huang, Yi-Wen Huang, Sien-Sing Yang, Wen-Ching Huang, Hsiao-Li Chuang. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic SteatohepatitisNutrients 2017; 9(11): 1220 doi: 10.3390/nu9111220
58
Peter S. Micalos, Sok Cheon Pak, Soo Liang Ooi. Modified Rice Bran Arabinoxylan2023; : 135 doi: 10.1007/978-981-19-5735-2_12
59
Hye-Kyung Chung, Ji Sun Nam, Mi-Yeon Lee, Yong-Bum Kim, Yu-Sam Won, Won-Jun Song, Young-Hwan Kim, Chul Woo Ahn, Ki-Chul Sung. The increased amount of coffee consumption lowers the incidence of fatty liver disease in Korean menNutrition, Metabolism and Cardiovascular Diseases 2020; 30(10): 1653 doi: 10.1016/j.numecd.2020.05.026
60
N. R. Matkovska, N. H. Virstiuk, U. V. Balan, I. O. Kostitska, M. S. Voloshynovych, N. V. Chaplynska, V. T. Rudnyk. CLINICAL AND LABORATORY MANIFESTATIONS OF ALCOHOLIC LIVER DISEASE AT THE CIRRHOSIS STAGE ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON DISEASE COMPENSATIONWorld of Medicine and Biology 2022; 18(79): 94 doi: 10.26724/2079-8334-2022-1-79-94-98
61
Tie-Ning Zhang, Wei Wang, Ni Yang, Xin-Mei Huang, Chun-Feng Liu. Regulation of Glucose and Lipid Metabolism by Long Non-coding RNAs: Facts and Research ProgressFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00457
62
Suryakant Niture, Maxwell A. Gyamfi, Minghui Lin, Uchechukwu Chimeh, Xialan Dong, Weifan Zheng, John Moore, Deepak Kumar. TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferationCell Death & Disease 2020; 11(3) doi: 10.1038/s41419-020-2369-4
63
Parcival Maissan, Eva Mooij, Matteo Barberis. Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic ReviewBiology 2021; 10(3): 194 doi: 10.3390/biology10030194
64
Zeinab Ghorbani, Masoomeh Hajizadeh, Azita Hekmatdoost. Dietary supplementation in patients with alcoholic liver disease: a review on current evidenceHepatobiliary & Pancreatic Diseases International 2016; 15(4): 348 doi: 10.1016/S1499-3872(16)60096-6
65
Yoosoo Chang, Juhee Cho, Yong Kyun Cho, Ara Cho, Yun Soo Hong, Di Zhao, Jiin Ahn, Chong Il Sohn, Hocheol Shin, Eliseo Guallar, Seungho Ryu. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular DiseasesClinical Gastroenterology and Hepatology 2020; 18(1): 205 doi: 10.1016/j.cgh.2019.05.004
66
Julian Wangler, Michael Jansky. Evaluation of elevated liver values in primary care - a series of studies on the status quo of care in Germany with special reference to alcoholic liver diseaseBMC Primary Care 2022; 23(1) doi: 10.1186/s12875-022-01714-x
67
Julian Wangler, Michael Jansky. Diagnostik erhöhter Leberwerte in der Primärversorgung – Befunde einer Studienreihe aus haus- und fachärztlicher PerspektiveZeitschrift für Gastroenterologie 2023; 61(04): 381 doi: 10.1055/a-1852-9822
68
Lingchong Liu, Yu Wang, Jing Zhang, Chao Wang, Youbao Li, Weichang Dai, Chunhong Piao, Junmei Liu, Hansong Yu, Xia Li, Yuhua Wang, Jingsheng Liu. Probiotics in treating with alcoholic liver disease and nonalcoholic fatty liver diseaseFood Reviews International 2023; 39(5): 2723 doi: 10.1080/87559129.2021.1967380
69
Hyun Jin Jung, Kyohee Cho, Sun Yeou Kim, Je Kyung Seong, Seung Hyun Oh. Ethanol extract of Pharbitis nil ameliorates liver fibrosis through regulation of the TGFβ1-SMAD2/3 pathwayJournal of Ethnopharmacology 2022; 294: 115370 doi: 10.1016/j.jep.2022.115370
70
Junling Wang, Ping Li, Zhilong Jiang, Qiuhui Yang, Yuqiang Mi, Yonggang Liu, Ruifang Shi, Yonghe Zhou, Jinsheng Wang, Wei Lu, Si Li, Dan Liu. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLDThe Korean Journal of Internal Medicine 2016; 31(3): 479 doi: 10.3904/kjim.2015.253
71
J. S. Metcalf, R. A. Dunlop, J. T. Powell, S. A. Banack, P. A. Cox. L-Serine: a Naturally-Occurring Amino Acid with Therapeutic PotentialNeurotoxicity Research 2018; 33(1): 213 doi: 10.1007/s12640-017-9814-x
72
Shivani Gandhi, Reetika Menia, Ishani Gupta, Surbhi Mahajan. New Perspectives for Post-mortem Examination [Working Title]2023;  doi: 10.5772/intechopen.1002066
73
Mohamed Diwan M. AbdulHameed, Venkat R. Pannala, Anders Wallqvist. Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome PathwaysFrontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01007
74
Alexandra Manchel, Radhakrishnan Mahadevan, Ramon Bataller, Jan B. Hoek, Rajanikanth Vadigepalli. Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic HepatitisMetabolites 2022; 12(12): 1157 doi: 10.3390/metabo12121157
75
Joy Ito, Hector Lemus, Tianying Wu. Serum Phosphorus, Serum Bicarbonate, and Renal Function in Relation to Liver CYP1A2 ActivityDiagnostics 2023; 13(18): 2996 doi: 10.3390/diagnostics13182996
76
Jin-Zhou Zhu, Qin-Yi Zhou, Yu-Ming Wang, Yi-Ning Dai, Jiang Zhu, Chao-Hui Yu, You-Ming Li. Prevalence of fatty liver disease and the economy in China: A systematic reviewWorld Journal of Gastroenterology 2015; 21(18): 5695-5706 doi: 10.3748/wjg.v21.i18.5695
77
Andrija Matetic, Tahmeed Contractor, Mohamed O. Mohamed, Rahul Bhardwaj, Ashish Aneja, Phyo K. Myint, Mina O. Rakoski, Shelley Zieroth, Timir K. Paul, Mamas A. Mamas. Trends, management and outcomes of acute myocardial infarction in chronic liver diseaseInternational Journal of Clinical Practice 2021; 75(4) doi: 10.1111/ijcp.13841
78
Anca Trifan, Cristina-Maria Muzica, Robert Nastasa, Sebastian Zenovia, Ermina Stratina, Remus Stafie, Adrian Rotaru, Ana-Maria Singeap, Camelia Cojocariu, Catalin Sfarti, Irina Girleanu, Stefan Chiriac, Tudor Cuciureanu, Laura Huiban, Carol Stanciu. High prevalence of liver fibrosis among general population: a Romanian population-based studyHepatology Communications 2023; 7(2): e0032 doi: 10.1097/HC9.0000000000000032
79
Caroline E Geisler, Benjamin J Renquist. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormonesJournal of Endocrinology 2017; 234(1): R1 doi: 10.1530/JOE-16-0513
80
Ram B. Jain, Alan Ducatman. Selective Associations of Recent Low Concentrations of Perfluoroalkyl Substances With Liver Function BiomarkersJournal of Occupational & Environmental Medicine 2019; 61(4): 293 doi: 10.1097/JOM.0000000000001532
81
Chiao-Wei Lin, Ting-Wei Huang, Yu-Ju Peng, Yuan-Yu Lin, Harry John Mersmann, Shih-Torng Ding. A novel chicken model of fatty liver disease induced by high cholesterol and low choline dietsPoultry Science 2021; 100(3): 100869 doi: 10.1016/j.psj.2020.11.046
82
Giovanni Tarantino, Vincenzo Citro. What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02031-1
83
Hitoshi Maeda, Yu Ishima, Junji Saruwatari, Yuki Mizuta, Yuki Minayoshi, Shota Ichimizu, Hiroki Yanagisawa, Taisei Nagasaki, Kengo Yasuda, Shun Oshiro, Manabu Taura, Matthew J. McConnell, Kentaro Oniki, Kayoko Sonoda, Tomohiko Wakayama, Manabu Kinoshita, Tsuyoshi Shuto, Hirofumi Kai, Motohiko Tanaka, Yutaka Sasaki, Yasuko Iwakiri, Masaki Otagiri, Hiroshi Watanabe, Toru Maruyama. Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASHJournal of Controlled Release 2022; 341: 457 doi: 10.1016/j.jconrel.2021.11.039
84
Eun-Hee Nah, Seon Cho, Suyoung Kim, Jieun Chu, Eunjoo Kwon, Han-Ik Cho. Prevalence of liver fibrosis and associated risk factors in the Korean general population: a retrospective cross-sectional studyBMJ Open 2021; 11(3): e046529 doi: 10.1136/bmjopen-2020-046529
85
Jian Ju, Mozaniel Santana de Oliveira, Yu Qiao. Cinnamon: A Medicinal Plant and A Functional Food SystemsFood Bioactive Ingredients 2023; : 231 doi: 10.1007/978-3-031-33505-1_16
86
Ana Murillo, Siqi Hu, Maria Fernandez. Zeaxanthin: Metabolism, Properties, and Antioxidant Protection of Eyes, Heart, Liver, and SkinAntioxidants 2019; 8(9): 390 doi: 10.3390/antiox8090390
87
Sedralmontaha Istanbuly, Andrija Matetic, Mohamed O. Mohamed, Sidakpal Panaich, Poonam Velagapudi, Islam Y. Elgendy, Timir K Paul, Mohamad Alkhouli, Mamas A. Mamas. Comparison of Outcomes of Patients With Versus Without Chronic Liver Disease Undergoing Percutaneous Coronary InterventionThe American Journal of Cardiology 2021; 156: 32 doi: 10.1016/j.amjcard.2021.06.044
88
Hideki Fujii, Naoki Nishimoto, Seiko Yamaguchi, Osamu Kurai, Masato Miyano, Wataru Ueda, Hiroko Oba, Tetsuya Aoki, Norifumi Kawada, Kiyotaka Okawa. The Alcohol Use Disorders Identification Test for Consumption (AUDIT-C) is more useful than pre-existing laboratory tests for predicting hazardous drinking: a cross-sectional studyBMC Public Health 2016; 16(1) doi: 10.1186/s12889-016-3053-6
89
Aleksandra Hliwa, Adriana Mika, Maciej Sledzinski, Dariusz Laski, Bruno Ramos-Molina, Tomasz Sledzinski. Changes in the Serum Fatty Acid Profile After Anhepatic Phase of Orthotopic Liver Transplantation ProcedureFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.817987
90
Melynda S. Coker, Kaylee R. Ladd, Jimin Kim, Carl J. Murphy, Ryan DeCort, Bradley R. Newcomer, Robert R. Wolfe, Robert H. Coker. Essential Amino Acid Supplement Lowers Intrahepatic Lipid despite Excess Alcohol ConsumptionNutrients 2020; 12(1): 254 doi: 10.3390/nu12010254
91
Alba Meneses, José Manuel Santabárbara, Juan Antonio Romero, Roberto Aliaga, Alicia María Maceira, David Moratal. Determination of Non-Invasive Biomarkers for the Assessment of Fibrosis, Steatosis and Hepatic Iron Overload by MR Image Analysis. A Pilot StudyDiagnostics 2021; 11(7): 1178 doi: 10.3390/diagnostics11071178
92
Yuanqiang Ma, Gyurim Lee, Su-Young Heo, Yoon-Seok Roh. Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver DiseaseAntioxidants 2021; 11(1): 91 doi: 10.3390/antiox11010091
93
Ram B. Jain. Concentration of selected liver enzymes across the stages of glomerular function: the associations with PFOA and PFOSHeliyon 2019; 5(7): e02168 doi: 10.1016/j.heliyon.2019.e02168
94
Szu-Yi Liu, I-Ting Tsai, Yin-Chou Hsu. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical PerspectivesInternational Journal of Molecular Sciences 2021; 22(10): 5170 doi: 10.3390/ijms22105170
95
Hyeong-Geug Kim, Jing-Hua Wang, Hyo-Seon Kim, Jin-Seok Lee, Hwi-Jin Im, Sung-Bae Lee, Dong-soo Lee, Gang-Min Hur, Chang-Gue Son. Animal Evidence for Synergistic Induction of Hepatic Injury by Dietary Fat and Alcohol Consumption and Its Potential MechanismsJournal of Personalized Medicine 2021; 11(4): 287 doi: 10.3390/jpm11040287